Product Recalls and Compensation Costs Arising from Unexpected Quality Issues
First written in FY2018. 17 of 18 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2025: 13 of 34 companies on the "Worse" side.
48 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「In terms of quality, we are addressing defects that escape detection and defects occurring within the production process, while strengthening our quality control system, including at overseas facilities.」
Under the Quality Assurance Committee, efforts to strengthen the quality control system, including at overseas facilities, are continuing. - FY2024RestatedAnnual report
「As a Group in which contract manufacturing accounts for more than 90% of operations, we believe our raison d'être lies in product quality. The Quality Assurance Committee has held extensive discussions to minimize the occurrence of defective products, accumulated knowledge and experience, and continues its daily efforts toward zero defects.」
The risk of recall and compensation costs arising from quality issues continues to be disclosed, with concrete efforts toward zero defective products being pursued through the Quality Assurance Committee. - FY2024-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2024-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2024-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2023-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2022RestatedAnnual report
「For the Group, we are making the maintenance and improvement of quality in overseas operations, which are increasingly becoming the main production base, our top priority, in addition to our domestic business.」
The risk of recall and compensation costs arising from quality issues continues to be disclosed, with maintaining and improving quality in overseas operations identified as the top priority. - FY2022-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2022-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2022-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2021-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2021-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2020-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2020-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2019RestatedAnnual report
「For the Group, we are making the maintenance and improvement of quality in overseas operations, which are increasingly becoming the main production base, our top priority, not only in our domestic business.」
The risk of recall and compensation costs arising from quality issues continues to be disclosed, with maintaining and improving quality in overseas operations identified as the top priority. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The treatment of the risk of recall and compensation costs arising from quality issues as having no new occurrence or material change remains unchanged. - FY2018First statedAnnual report
「The Group makes every effort to ensure product quality. However, if unexpected quality issues result in substantial recall and compensation costs, the Group's business results and financial condition may be affected.」
The company discloses the possibility that unexpected product quality issues could affect business results and financial condition through recall and compensation costs.